β2-Adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis

Trends in Pharmacological Sciences

Volumn 25, Issue 2, 2004, Pages 67-71

  De Keyser, Jacques ^a   Zeinstra, Esther ^a   Mostert, Jop ^a   Wilczak, Nadine ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CALCIUM ION; CYCLIC AMP; GAMMA INTERFERON; GLYCOGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN;

ANTIGEN PRESENTING CELL; ASTROCYTE; BIOACCUMULATION; CALCIUM CELL LEVEL; CELL CULTURE; CELL ENERGY; CELL TRANSFORMATION; DEMYELINATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY RESOURCE; GLYCOGENOLYSIS; HUMAN; HYPOTHESIS; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RELAPSE; REVIEW; T LYMPHOCYTE; WHITE MATTER;

EID: 0842266254     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.12.002     Document Type: Article

References (50)

1. Noseworthy J.H., et al. Multiple sclerosis. New Engl. J. Med. 343:2000;938-952.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
3. Hellings N., et al. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 63:2001;290-302.
4. Hellings N., et al. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. J. Neuroimmunol. 126:2002;143-160.
5. Wekerle H. T-cell autoimmunity in the central nervous system. Intervirology. 35:1993;95-100.
6. Kimelberg H.K. Receptors on astrocytes - what possible functions? Neurochem. Int. 26:1995;27-40.
7. De Keyser J., et al. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology. 53:1999;1628-1633.
8. Mantyh P.W., et al. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J. Neurosci. 15:1995;152-164.
9. Paspalas C.D., Papadopoulos G.C. Ultrastructural relationships between noradrenergic nerve fibers and non-neuronal elements in the rat cerebral cortex. Glia. 17:1996;133-146.
10. Cohen Z., et al. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J. Cereb. Blood Flow Metab. 17:1997;894-904.
11. 3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 289:2000;75-77.
12. Niino M., et al. An examination of the association between beta2 adrenergic receptor polymorphisms and multiple sclerosis. Mult. Scler. 8:2002;475-478.
13. Mutinelli F., et al. Astrocytic infection in canine distemper virus-induced demyelination. Acta Neuropathol. (Berl.). 77:1989;333-335.
14. Koschel K., Muenzel P. Persistent paramyxovirus infections and behaviour of beta-adrenergic receptors in C-6 rat glioma cells. J. Gen. Virol. 47:1980;513-517.
15. De Keyser J., et al. Disappearance of beta2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosis. NeuroReport. 12:2001;191-194.
16. Lassmann H., et al. A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. Brain. 126:2003;1347-1357.
17. Feinstein D.L. Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity. J. Neurochem. 70:1998;1484-1496.
18. Feinstein D.L., et al. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 41:2002;357-365.
19. Perrin P.J., et al. Differential requirements of naive and memory T cells for CD28 costimulation in autoimmune pathogenesis. Histol. Histopathol. 14:1999;1269-1276.
20. Racke M.K., et al. The role of costimulation in autoimmune demyelination. J. Neuroimmunol. 107:2000;205-215.
21. Markovic-Plese S., et al. CD4+CD28 - costimulation-independent T cells in multiple sclerosis. J. Clin. Invest. 108:2001;1185-1194.
22. Scholz C., et al. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1998;1532-1538.
23. Zeinstra E., et al. Reactive astrocytes in chronic active lesions of multiple sclerosis express costimulatory molecules B7-1 and B7-2. J. Neuroimmunol. 135:2003;166-171.
24. Ulvestad E., et al. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology. 82:1994;535-541.
25. De Keyser J., et al. Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch. Neurol. 60:2003;132-136.
26. Frohman E.M., et al. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1292-1296.
27. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98:1999;77-88.
28. De Groot C.J., et al. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:1997;10-20.
29. Liu J.S., et al. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2001;2057-2066.
30. Smith K.J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1:2002;232-241.
31. Bjartmar C., et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48:2000;893-901.
32. De Stefano N., et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch. Neurol. 59:2002;1565-1571.
33. De Stefano N., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58:2001;65-70.
34. Lee M.A., et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch. Neurol. 57:2000;65-70.
35. Simon J.H., et al. A wallerian degeneration pattern in patients at risk for MS. Neurology. 54:2000;1155-1160.
36. Kidd D., et al. Cortical lesions in multiple sclerosis. Brain. 122:1999;17-26.
37. Confavreux C., et al. Relapses and progression of disability in multiple sclerosis. New Engl. J. Med. 343:2000;1430-1438.
38. Coles A.J., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 46:1999;296-304.
39. Burt R.K., et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of intense immune suppression to prevent disease progression in patients with high disability scores. Blood. 102:2003;2373-2378.
40. Fillenz M., et al. The role of astrocytes and noradrenaline in neuronal glucose metabolism. Acta Physiol. Scand. 167:1999;275-284.
41. Brown A.M., et al. Glycogen regulation and functional role in mouse white matter. J. Physiol. 549:2003;501-512.
42. Black J.A., Waxman S.G. The perinodal astrocyte. Glia. 1:1988;169-183.
43. Sorg O., Magistretti P.J. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res. 563:1991;227-233.
44. Wender R., et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 20:2000;6804-6810.
45. Allaman I., et al. Protein targeting to glycogen mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia. 30:2000;382-391.
46. Ransom B.R., Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia. 21:1997;134-141.
47. Petty M.A., Wettstein J.G. White matter ischaemia. Brain Res. Brain Res. Rev. 31:1999;58-64.
48. Schon E.A., Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. 111:2003;303-312.
49. Ballestas M.E., Benveniste E.N. Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression. J. Neurochem. 69:1997;1438-1448.
50. Zeinstra E., et al. Aminergic receptors in astrogliotic plaques from patients with multiple sclerosis. Neurosci. Lett. 331:2002;87-90.